R. Brooks Robey, M.D.
Associate Professor of Medicine
Associate Professor of Physiology and Neurobiology
Associate Chief of Staff for Research, White River Junction VAMC
Founding Chief, Section of Nephrology and Hypertension, White River Junction VAMC
Inaugural Director, Northern New England Research Consortium (White River Junction VAMC [VT], Manchester VAMC [NH], VA Maine HCS [ME], and Central Western Massachusetts VAMC [MA])
Physiology and Neurobiology
B.S. with Honors in Chemical Biology, Rhodes College (1981)
M.D., University of Arkansas for Medical Sciences (1985)
Intern, Internal Medicine, University of Arkansas (1985-1986)
Resident, Internal Medicine, University of Arkansas (1986-1988)
Research Fellow, Molecular Physiology, LKEM, NHLBI, NIH (1988-1991)
Clinical Fellow, Nephrology, Vanderbilt University (1991-1994)
Research Fellow, Molecular Physiology, Vanderbilt University (1992-1996)
Program in Experimental and Molecular Medicine
c/o WRJVAMC R&D Svc (151)
215 N Main St
White River Jct VT 05009-0001
Scientific Basis of Medicine (FEK)
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
Varenicline for smoking reduction prior to cessation.
Cyclical dehydration-induced renal injury and Mesoamerican nephropathy: as sweet by any other name?
Changing the terminology of cancer.
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Peptides modeled on the RGG domain of AUF1/hnRNP-D regulate 3' UTR-dependent gene expression.
"Does sunscreen promote hypertension?" and other questions. Novel interactions between vitamin D and the renin-angiotensin axis. Focus on "The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system".
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease.
Potassium levels after acute myocardial infarction.